Plenty Of Potential For Roche's Entrectinib Despite Lack Of ESMO Enthusiasm

 
• By Kevin Grogan
  
Star Trek
Set Phasers to Stun: Solid data from entrectinib's STARTRK trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D